Company Profiles

driven by the PitchBook Platform

Adgero Biopharmaceuticals

Adgero Biopharmaceuticals
2007 FOUNDED
IPO REG STATUS
1-10 EMPLOYEES
IPO LATEST DEAL TYPE (Announced)
$17.3M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of a late stage photodynamic therapy platform designed for the treatment of serious oncology indications. The company's platform uses photosensitizers that, when exposed to light, act as a catalyst to produce a form of oxygen that induces local tumor cell death enabling doctors to treat serious oncology indications.

Ownership Status
In IPO Registration
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Primary Office
3 Davenport Drive
Princeton Junction, NJ 08850
United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adgero Biopharmaceuticals’s full profile, request a free trial.

Adgero Biopharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. IPO 14-Feb-2017 $17.3M 000.00 000.00 Announced Generating Revenue/Not Profitable
4. Corporate 22-Feb-2017 000 000.00 Completed Clinical Trials - Phase 3
3. Angel (individual) 16-Sep-2016 00.00 000.00 Completed Clinical Trials - Phase 3
2. Angel (individual) 19-Apr-2016 $3.02M $3.06M Completed Clinical Trials - Phase 3
1. Angel (individual) 23-Nov-2015 $39.8K $39.8K Completed Clinical Trials - Phase 3
To view this company’s complete deal history including valuation and funding, request access »

Adgero Biopharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Corporation Minority 000 0000 000000 0

Adgero Biopharmaceuticals Executive Team (5)

Name Title Board
Seat
Contact
Info
Frank Pilkiewicz Ph.D Founder, Chairman, Chief Executive Officer & President
Jane Maida Chief Financial Officer
John Liatos Chief Financial Officer
Laura Edgerly-Pflug Vice President, Manufacturing Operations and Quality Control
Steve Rychnovsky Ph.D Vice President, Operations & Product Development

Adgero Biopharmaceuticals Board Members (4)

Name Representing Role Since Contact
Info
Allen Bloom Adgero Biopharmaceuticals Board Member 000 0000
David Hochman Adgero Biopharmaceuticals Board Member 000 0000
Roman Perez-Soler MD Self Board Member 000 0000
Tim McInerney Adgero Biopharmaceuticals Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com